This federal contract award provides $23,695,035.31 in clinical trial reporting program support services to the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract was awarded to Essex Management LLC, a private life sciences IT consulting and recruiting company, and does not have a set-aside designation. The period of performance runs from July 28, 2020 through July 27, 2025. This contract is a Delivery Order issued under Essex Management's existing Multiple Award Schedule (MAS) contract with the General Services Administration (GSA). The company has received numerous prior federal contract awards to provide specialized services, including data management, analytics, reporting, and subject matter expertise, in support of NCI programs such as the National Childhood Cancer Registry and Childhood Cancer Data Initiative.
Generated 1/14/25, 9:20 AM